Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
Legal · TXJune 3, 2026

Texas Appeals Court Denies Novartis Petition to Halt Medicaid Fraud Qui Tam Case

The Fifteenth Court of Appeals in Texas denied Novartis Pharmaceuticals' request for mandamus relief to halt a Medicaid qui tam action brought under the Texas Medicaid Fraud Prevention Act (TMFPA). While the court acknowledged "weighty" constitutional questions raised by Novartis regarding the TMFPA's qui tam provisions, it ruled that these challenges must be addressed through ordinary appellate review rather than through extraordinary mandamus relief. The decision allows the underlying fraud case to proceed. The ruling affirms that constitutional challenges to state Medicaid fraud statutes, even when substantial, do not automatically warrant immediate appellate intervention before trial court resolution.

Why it mattersMedicaid managed care organizations facing TMFPA qui tam actions cannot immediately halt litigation through constitutional challenges, requiring them to defend through full trial proceedings with potential liability exposure during extended litigation timelines.

Managed Care

Read the full article at hallrender.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.